This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, United Kingdom, United States, South Africa
The drug ZOMIG contains one active pharmaceutical ingredient (API):
|
1
Zolmitriptan
UNII 2FS66TH3YW - ZOLMITRIPTAN
|
|
Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZOMIG Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| ZOMIG Nasal spray | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02CC03 | Zolmitriptan | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8266C |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 542818090002117, 542818090002217 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02238660, 02243045, 02248992, 02248993 |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00784674, 02759982, 09279156 |
| Country: EE | Ravimiamet | Identifier(s): 1110722, 1110733, 1179716 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 3110988, 34009, 61826, 62928, 65163, 65795 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 005303, 184432, 435594 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68232350, 68354386 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139961, 139963, 147367, 21567, 36406, 373755, 373757, 48207, 81566 |
| Country: HK | Department of Health Drug Office | Identifier(s): 43324 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 57916, 57947, 57974, 58020, 58026 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3617 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 033345012, 033345149 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2160004F1027, 2160004F2023 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003212, 1086335, 1088487, 1093339 |
| Country: MT | Medicines Authority | Identifier(s): AA227/00703, AA908/20401 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 356M2000, 612M97 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 47651, 55727 |
| Country: SG | Health Sciences Authority | Identifier(s): 11816P |
| Country: US | FDA, National Drug Code | Identifier(s): 64896-671, 64896-672, 64896-681, 64896-682, 64896-691, 64896-692 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/7.3/0479, 34/7.3/0107, 36/7.3/0133 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
